Intrinsic Value of S&P & Nasdaq Contact Us

Becton, Dickinson and Company BDX NYSE

NYSE • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
$318.86
+104.8%
Analyst Price Target
$193.80
+24.4%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Becton, Dickinson and Company (BDX) trades at a trailing P/E of 25.3, forward P/E of 12.5. Trailing earnings yield is 3.95%, forward earnings yield 8.02%. PEG 0.11 (Peter Lynch undervalued ≤1.0). Graham Number is $110.90.

Criteria proven by this page:

  • VALUE (36/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
  • Forward P/E 12.5 (down from trailing 25.3) — analysts expect earnings to grow, which would improve the valuation.
  • PEG Ratio 0.11 — below 1.0 suggests the stock is undervalued relative to its earnings growth rate (Peter Lynch criterion).
  • Trailing Earnings Yield 3.95% — roughly competitive with bond yields (~4.3%), moderate risk-reward. Forward yield improves to 8.02% as earnings recover.
  • Analyst consensus target $193.80 (+24.4% upside) — significant upside potential according to Wall Street analysts.

Overall SharesGrow Score: 56/100 with 2/7 criteria passed.

SharesGrow 7-Criteria Score
56/100
SG Score
View full scorecard →
VALUE
36/100
Price-to-Earnings & upside
Proven by this page
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
→ Health
MOAT
73/100
→ Income
~
GROWTH
40/100
→ Income
~
INCOME
45/100
→ Income

Valuation Snapshot — BDX

Valuation Multiples
P/E (TTM)25.3
Forward P/E12.5
PEG Ratio0.11
Forward PEG0.11
P/B Ratio1.76
P/S Ratio2.58
EV/EBITDA14.7
Per Share Data
EPS (TTM)$6.16
Forward EPS (Est.)$12.49
Book Value / Share$88.69
Revenue / Share$76.90
FCF / Share$9.23
Yields & Fair Value
Earnings Yield3.95%
Forward Earnings Yield8.02%
Dividend Yield2.25%
Graham Number$110.90
SharesGrow IV$318.86 (+104.8%)
Analyst Target$193.80 (+24.4%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 23.6 0.70 3.02 1.85 2.44%
2017 23.5 9.81 2.00 2.14 2.62%
2018 132.3 -1.52 1.96 2.58 2.25%
2019 33.4 0.06 1.95 2.38 2.39%
2020 44.8 -1.46 1.65 2.43 2.62%
2021 20.5 0.14 1.81 2.24 2.45%
2022 22.1 -1.54 1.55 2.08 2.76%
2023 30.8 -1.90 1.77 2.36 2.44%
2024 25.3 1.38 1.67 2.14 2.55%
2025 19.8 -29.05 1.31 1.52 3.61%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $4.49 $12.48B $976M 7.8%
2017 $4.60 $12.09B $1.1B 9.1%
2018 $1.18 $15.98B $311M 1.9%
2019 $3.94 $17.29B $1.22B 7.1%
2020 $2.72 $17.12B $874M 5.1%
2021 $6.85 $20.25B $2.09B 10.3%
2022 $5.88 $18.87B $1.78B 9.4%
2023 $4.94 $19.37B $1.48B 7.7%
2024 $5.86 $20.18B $1.71B 8.4%
2025 $5.83 $21.84B $1.68B 7.7%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $12.53 $12.38 – $12.93 $19.24B $19.04B – $19.8B 6
2027 $13.46 $12.70 – $15.58 $19.67B $19.56B – $19.77B 7
2028 $14.28 $14.15 – $14.58 $20.36B $20.29B – $20.42B 1
2029 $15.63 $15.48 – $15.95 $21.12B $20.97B – $21.46B 1
2030 $16.91 $16.75 – $17.26 $21.9B $21.74B – $22.25B 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message